Authors:
KIRAZ S
BALTALI E
GULER N
BARISTA I
BENEKLI M
CELIK I
GULLU IH
KARS A
TEKUZMAN G
FIRAT D
Citation: S. Kiraz et al., IFOSFAMIDE, MESNA AND EPIRUBICIN AS 2ND-LINE CHEMOTHERAPY IN ADVANCEDBREAST-CANCER, Journal of chemotherapy, 8(4), 1996, pp. 310-314
Authors:
CELIK I
KARS A
OZYAR E
TEKUZMAN G
ATAHAN L
FIRAT D
Citation: I. Celik et al., MAJOR TOXICITY OF CISPLATIN, FLUOROURACIL, AND LEUCOVORIN FOLLOWING CHEMORADIOTHERAPY IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA, Journal of clinical oncology, 14(3), 1996, pp. 1043-1044
Citation: M. Arici et al., SYNCHRONOUS DEVELOPMENT OF RENAL-CELL CARCINOMA WITH GLIOBLASTOMA-MULTIFORME, Journal of experimental & clinical cancer research, 15(4), 1996, pp. 415-415
Authors:
BARISTA I
BALTALI E
GULLU IH
GULER N
CELIK I
SARACBASI O
TEKUZMAN G
KARS A
OZISIK Y
RUACAN S
ATAHAN IL
FIRAT D
Citation: I. Barista et al., FACTORS INFLUENCING THE DISTRIBUTION OF METASTASES AND SURVIVAL IN METASTATIC BREAST-CARCINOMA, American journal of clinical oncology, 19(6), 1996, pp. 569-573
Authors:
YALCIN S
BARISTA I
TEKUZMAN G
GULLU I
FIRAT D
Citation: S. Yalcin et al., DRAMATIC RESPONSE TO IFOSFAMIDE, MESNA AND DOXORUBICIN CHEMOTHERAPY REGIMEN IN AN ADULT WITH CLEAR-CELL SARCOMA OF THE KIDNEY, The Journal of urology, 155(6), 1996, pp. 2024-2024
Authors:
KARS A
CELIK I
KANSU E
OZISIK Y
GULER N
BARISTA I
GULLU IH
YALCIN S
ALTUNDAG K
ZENGIN N
TEKUZMAN G
BALTALI E
FIRAT D
Citation: A. Kars et al., VINCRISTINE, ADRIAMYCIN AND DEXAMETHASONE CHEMOTHERAPY WITH OR WITHOUT INTERFERON-ALPHA-2B MAINTENANCE IN MULTIPLE-MYELOMA, Blood, 88(10), 1996, pp. 3609-3609
Authors:
GULER N
BALTALI E
KARS A
OZISIK Y
ENUNLU T
TEKUZMAN G
OZYILKAN O
ONAT D
GULLU I
BARISTA I
FIRAT D
Citation: N. Guler et al., CMF OR CMF-IIIA BREAST-CARCINOMA(RT AS ADJUVANT THERAPY IN PATIENTS WITH STAGE I), European journal of cancer, 31A, 1995, pp. 70-70
Authors:
YALCIN S
GULER N
KANSU E
ERTENLI I
GULLU I
KARS A
AKPEK G
BARISTA I
TEKUZMAN G
BALTALI E
Citation: S. Yalcin et al., GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) ADMINISTRATION FOR CHEMOTHERAPY-INDUCED NEUTROPENIA, European journal of cancer, 31A, 1995, pp. 591-591
Authors:
BARISTA I
TEKUZMAN G
GULLU I
BALTALI E
KARS A
OZISIK Y
GULER N
CELIK I
ATAHAN IL
FIRAT D
Citation: I. Barista et al., NON-HODGKINS-LYMPHOMAS OF THE TONSIL - A RETROSPECTIVE ANALYSIS OF 28PATIENTS WITH PRIMARY TONSILLARY LYMPHOMA, Tumori, 81(4), 1995, pp. 234-237
Authors:
AKOVA M
AKALIN HE
UZUN O
HAYRAN M
TEKUZMAN G
KANSU E
ASLAN S
TELATAR H
Citation: M. Akova et al., EFFICACY OF FLUCONAZOLE IN THE TREATMENT OF UPPER GASTROINTESTINAL CANDIDIASIS IN NEUTROPENIC PATIENTS WITH CANCER - FACTORS INFLUENCING THE OUTCOME, Clinical infectious diseases, 18(3), 1994, pp. 298-304
Authors:
BARISTA I
TEKUZMAN G
FIRAT D
BALTALI E
KANSU E
KARS A
OZISIK Y
RUACAN S
UZUNALIMOGLU B
KARAAGAOGLU E
Citation: I. Barista et al., NON-HODGKINS-LYMPHOMAS IN TURKEY - 18 YEARS EXPERIENCE AT THE HACETTEPE-UNIVERSITY, Japanese journal of cancer research, 85(12), 1994, pp. 1200-1207
Authors:
ZORLU AF
ATAHAN IL
GEDIKOGLU G
RUACAN S
SAYEK I
TEKUZMAN G
Citation: Af. Zorlu et al., DOES GASTRIC ADENOCARCINOMA DEVELOP AFTER THE TREATMENT OF GASTRIC LYMPHOMA, Journal of surgical oncology, 54(2), 1993, pp. 126-131